Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Understanding the Clinical Implications of Low Penetrant Genes and Breast Cancer Risk.

Current treatment options in oncology - 23 Aug 2021

Vaidyanathan Anusha, Kaklamani Virginia

Abstract excerpt

OPINION STATEMENT: Since the 2013 Supreme Court declaration, panel testing for hereditary cancer syndromes has evolved into the gold standard for oncology germline genetic testing. With the advent of next-generation sequencing, competitive pricing, and developing therapeutic options, panel testing is now well integrated into breast cancer management and surveillance. Although many established syndromes have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms, Hereditary Nonpolyposis
Share to DNA Mismatch Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fanconi Anemia Complementation Group Proteins

Share to Germ-Line Mutation

Share to Penetrance

Share to Population Surveillance

Share to RNA Helicases

Share to Ubiquitin-Protein Ligases

Source

Identifiers

PMID: 34424438
DOI: 10.1007/s11864-021-00887-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Understanding the Clinical Implications of Low Penetrant Genes and Breast Cancer Risk.PMID 34424438Read ↗

Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers.Semantic proximity Read ↗

Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.Semantic proximity Read ↗

Hereditary breast cancer syndromes and genetic testingSemantic proximity Read ↗

A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic ElementsSemantic proximity Read ↗

Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.Semantic proximity Read ↗

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?Semantic proximity Read ↗

Next-generation sequencing for inherited breast cancer risk: counseling through the complexity.Semantic proximity Read ↗

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.Semantic proximity Read ↗

Clinical genetics in breast cancer.Semantic proximity Read ↗

Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine.Semantic proximity Read ↗

Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention StrategiesSemantic proximity Read ↗

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast SurgeonsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.